Give Us The Good The Bad ,and The Ugly, page-8

Hi All,
Andreas was very apologetic for not being at the meeting in person - he said he felt the opportunity afforded by whoever he was meeting with was too good an opportunity not to take up, and that he hoped he could disclose more in due course.
Very few questions were asked. Whilst some might think it was an opportunity wasted to not ask the 'hard' questions, my perspective is the questions are reasonably obvious to all of us, so they are in fact not hard - it's the answers that are 'hard' in that they simply don't know how long it will take to get meaningful amounts of revenue. Having said that it appears that due to I-MED upgrading their own systems that as had a knock-on effect in that it was pointless in linking our system to a an I-MED system that was about to be be discarded so our roll-out was slowed accordingly.
Whilst the outgoing Chair left immediately (which I gather has happened before), the incoming Chair was there to the very end and came and spoke to myself, some other holders, and some staff that we were speaking to over a modest morning tea. They all reinforced the fact that they are all holders themselves, with their interests being very aligned with ours. They also assured us that cost control is very forefront in their minds, and being actively managed.
So for what it's worth my own reflection was that whilst progress is slower than what I would originally anticipated, the technological moat is still there, and the team seemed very focused on advancing the company commercially. So all in I anticipate continuing to hold.
DYOR.